Board of Directors
Fred Eshelman, Pharm.D.
Fred Eshelman, Pharm.D., is Furiex's founding chairman. He was the founder and executive chairman of Pharmaceutical Product Development, Inc. (Nasdaq: PPDI) prior to its sale to private equity.
Stuart Bondurant, M.D.
Stuart Bondurant, M.D., is emeritus dean and emeritus professor of medicine at the University of North Carolina at Chapel Hill School of Medicine.
Peter Corr, Ph.D.
Peter Corr, Ph.D., is co-founder and general partner of Celtic Therapeutics Management LLP. Dr. Corr retired from Pfizer Inc. in December 2006 where he was senior vice president for science and technology.
Wendy Dixon, Ph.D.
Wendy Dixon, Ph.D., has a 30-year career in the pharmaceutical and biotechnology business. From 2001 to 2009, she was chief marketing officer and president of global marketing for Bristol-Myers Squibb. From 1996 to 2001, she was senior vice president of marketing at Merck & Co., Inc.
Steve Kaldor, Ph.D.
Dr. Kaldor is a Venture Partner at Versant Ventures and acting CEO at Quanticell. Prior to this role, Dr. Kaldor served as president and chief executive officer of Ambrx, a San Diego-based biopharmaceutical company with a mission to deliver breakthrough protein therapeutics. Prior to Ambrx, he served as president and chief scientific officer of Takeda San Diego Inc., the US Discovery Research Center for Takeda Pharmaceuticals where he initiated and led the March 2005 $270 million acquisition of Syrrx Inc. by Takeda that resulted in the creation of Takeda San Diego. Dr. Kaldor ran Syrrx, a privately-held, structure-based drug discovery company, as its president and chief scientific officer from 2003 to 2005. He also has over 12 years of drug discovery and development experience at Eli Lilly and Company.
Robert Ruscher
Robert Ruscher has more than 20 years of experience in working closely with emerging growth, technology-based companies. Mr. Ruscher served as president and chief executive officer of Salix Pharmaceuticals, Inc. from 1999 to 2002, as executive chairman of the board from 2002 to 2003, and retired from Salix in 2005.
